2 hrs ago
Spectrum Pharmaceuticals Appoints New President and COO
Spectrum Pharmaceuticals , a biotechnology company with a primary focus in hematology and oncology, has appointed Joseph Turgeon, previously senior vice president and COO, as president and COO, replacing Ken Keller.
Trending on the Topix Network
Wed Apr 23, 2014
Ligand's Partner Spectrum Pharmaceuticals Reports Captisol-Enabled...
Ligand Pharmaceuticals Incorporated announces that its Captisol-enabled Melphalan development and commercial partner Spectrum Pharmaceuticals has reported that their pivotal trial of CE Melphalan met its primary endpoint.
Mon Apr 21, 2014
BioAlliance Pharma Acquires Biopharmaceutical Firm Topotarget
French pharmaceutical company BioAlliance Pharma has agreed to acquire the Scandinavian biopharmaceutical firm Topotarget.
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as...
'Joe was responsible for building a top sales organization and for launching four of the world's top-selling biologicals, during his over two decades at Amgen.
Fri Apr 18, 2014
Ken Keller Named President, US Commercial, Daiichi Sankyo, Inc.
In his role, Mr. Keller will be responsible for leading marketing, sales, medical affairs and supply chain operations for Daiichi Sankyo in the U.S. , President and CEO of Daiichi Sankyo Co., Ltd., the parent company of the Daiichi Sankyo Group.
Tue Apr 15, 2014
Analysts View on Biotech Equities -- Research on Organovo Holdings,...
The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 648.05, up 0.51%, while the same has fallen by 1.86% in the previous three months.
Tue Apr 08, 2014
Press release distribution, EDGAR filing, XBRL, regulatory filings
In first quarter 2014, ... )--Government Properties Income Trust today announced its regular quarterly common share distribution of $0.43 per common share .
View Press Release
If you own common stock in Spectrum Pharmaceuticals, Inc. and wish to obtain additional information, please contact Eduard Korsinsky, Esq.
Stock market live blog: S&P 500 breaks 3-day skid; Google, Yahoo, eBay rally
Rajesh C. Shrotriya, chairman and chief executive of Spectrum Pharmaceuticals, says with conviction that a lot of biotech shares are overvalued because, simply put, they've been "selling a dream" instead of focusing on fundamentals.
Mon Apr 07, 2014
Spectrum Pharmaceuticals Downgraded by TheStreet to "Sell"
The analysts wrote, "Spectrum Pharmaceuticals has been downgraded by TheStreet Ratings from hold to sell.
Tue Apr 01, 2014
Bangor Daily News
Varney Agency hires Lee Rossignol, director of sales
Varney Agency is pleased to announce the hiring of Lee Rossignol, director of sales.
Thu Mar 27, 2014
Topotarget announces financial results for the year ended Dec 31, 2013
A net loss in continued operations of ). Revenues are composed of milestone payments from the renegotiated agreement with Apricus Biosciences, Inc. and income per our collaboration agreement with Spectrum Pharmaceuticals.
Wed Mar 26, 2014
Topotarget confirms receipt of acceptance-to-file milestone payment
Topotarget A/S hereby confirms the receipt of the milestone payment of USD 10 million and 1 million shares from Spectrum Pharmaceuticals, Inc. related to the US Food and Drug Administration's recent acceptance to file BeleodaqTM for peripheral T-cell lymphoma .